Tatjana Bobylev
Elbe Kliniken Stade-Buxtehude(DE)
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Urticaria and Related Conditions, Autoimmune Bullous Skin Diseases, Mast cells and histamine
Most-Cited Works
- → Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation(2024)17 cited
- → Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study(2024)14 cited
- → Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study(2025)4 cited
- → Performance of omalizumab in patients with mast cell-mediated angioedema with and without wheals(2026)